{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:23:35Z","timestamp":1791559415326,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["T15 LM007093"],"award-info":[{"award-number":["T15 LM007093"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K08DK106453"],"award-info":[{"award-number":["K08DK106453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01NS107733"],"award-info":[{"award-number":["R01NS107733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32 GM07526-41"],"award-info":[{"award-number":["T32 GM07526-41"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Burroughs Wellcome Fund Career Award for Medical Scientists"},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["144213"],"award-info":[{"award-number":["144213"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Untargeted metabolomics is a global molecular profiling technology that can be used to screen for inborn errors of metabolism (IEMs). Metabolite perturbations are evaluated based on current knowledge of specific metabolic pathway deficiencies, a manual diagnostic process that is qualitative, has limited scalability, and is not equipped to learn from accumulating clinical data. Our purpose was to improve upon manual diagnosis of IEMs in the clinic by developing novel computational methods for analyzing untargeted metabolomics data. We employed CTD, an automated computational diagnostic method that \u201c<jats:bold><jats:underline>c<\/jats:underline><\/jats:bold>onnects <jats:bold><jats:underline>t<\/jats:underline><\/jats:bold>he <jats:bold><jats:underline>d<\/jats:underline><\/jats:bold>ots\u201d between metabolite perturbations observed in individual metabolomics profiling data and modules identified in disease\u00adspecific metabolite co-perturbation networks learned from prior profiling data. We also extended CTD to calculate distances between any two individuals (CTDncd) and between an individual and a disease state (CTDdm), to provide additional network-quantified predictors for use in diagnosis. We show that across 539 plasma samples, CTD-based network-quantified measures can reproduce accurate diagnosis of 16 different IEMs, including adenylosuccinase deficiency, argininemia, argininosuccinic aciduria, aromatic <jats:sc>l<\/jats:sc>-amino acid decarboxylase deficiency, cerebral creatine deficiency syndrome type 2, citrullinemia, cobalamin biosynthesis defect, GABA-transaminase deficiency, glutaric acidemia type 1, maple syrup urine disease, methylmalonic aciduria, ornithine transcarbamylase deficiency, phenylketonuria, propionic acidemia, rhizomelic chondrodysplasia punctata, and the Zellweger spectrum disorders. Our approach can be used to supplement information from biochemical pathways and has the potential to significantly enhance the interpretation of variants of uncertain significance uncovered by exome sequencing. CTD, CTDdm, and CTDncd can serve as an essential toolset for biological interpretation of untargeted metabolomics data that overcomes limitations associated with manual diagnosis to assist diagnosticians in clinical decision-making. By automating and quantifying the interpretation of perturbation patterns, CTD can improve the speed and confidence by which clinical laboratory directors make diagnostic and treatment decisions, while automatically improving performance with new case data.<\/jats:p>","DOI":"10.1038\/s41598-022-10415-5","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T09:03:57Z","timestamp":1650531837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clinical diagnosis of metabolic disorders using untargeted metabolomic profiling and disease-specific networks learned from profiling data"],"prefix":"10.1038","volume":"12","author":[{"given":"Lillian R.","family":"Thistlethwaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay C.","family":"Burrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Riehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Hacia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Wangler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Elsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Milosavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"issue":"10","key":"10415_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/humu.22858","volume":"36","author":"AA Philippakis","year":"2015","unstructured":"Philippakis, A. A. et al. The matchmaker exchange: A platform for rare disease gene discovery. Hum. Mutat. 36(10), 915\u2013921 (2015).","journal-title":"Hum. Mutat."},{"issue":"10","key":"10415_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/humu.22851","volume":"36","author":"OJ Buske","year":"2015","unstructured":"Buske, O. J. et al. PhenomeCentral: A portal for phenotypic and genotypic matchmaking of patients with rare genetic diseases. Hum. Mutat. 36(10), 931\u2013940 (2015).","journal-title":"Hum. Mutat."},{"issue":"5","key":"10415_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17(5), 405\u2013424 (2015).","journal-title":"Genet. Med."},{"issue":"11","key":"10415_CR4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/jms.4292","volume":"53","author":"AD Kennedy","year":"2018","unstructured":"Kennedy, A. D. et al. Metabolomics in the clinic: a review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing. J. Mass Spectrom. 53(11), 1143\u20131154 (2018).","journal-title":"J. Mass Spectrom."},{"issue":"6","key":"10415_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10545-015-9843-7","volume":"38","author":"MJ Miller","year":"2015","unstructured":"Miller, M. J. et al. Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism. J. Inherit. Metab. Dis. 38(6), 1029\u20131039 (2015).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10415_CR6","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/gim.2017.262","volume":"20","author":"MF Wangler","year":"2018","unstructured":"Wangler, M. F. et al. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers. Genet. Med. 20(10), 1274\u20131283 (2018).","journal-title":"Genet. Med."},{"issue":"9","key":"10415_CR7","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/s41436-019-0442-0","volume":"21","author":"LC Burrage","year":"2019","unstructured":"Burrage, L. C. et al. Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders. Genet. Med. 21(9), 1977\u20131986 (2019).","journal-title":"Genet. Med."},{"key":"10415_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgmr.2016.07.007","volume":"8","author":"TR Donti","year":"2016","unstructured":"Donti, T. R. et al. Diagnosis of adenylosuccinate lyase deficiency by metabolomic profiling in plasma reveals a phenotypic spectrum. Mol. Genet. Metab. Rep. 8, 61\u201366 (2016).","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"2\u20133","key":"10415_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ymgme.2015.04.008","volume":"115","author":"PS Atwal","year":"2015","unstructured":"Atwal, P. S. et al. Aromatic l-amino acid decarboxylase deficiency diagnosed by clinical metabolomic profiling of plasma. Mol. Genet. Metab. 115(2\u20133), 91\u201394 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"10415_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fnins.2019.00394","volume":"13","author":"AD Kennedy","year":"2019","unstructured":"Kennedy, A. D. et al. 2-pyrrolidinone and succinimide as clinical screening biomarkers for GABA-transaminase deficiency: Anti-seizure medications impact accurate diagnosis. Front. Neurosci. 13, 394 (2019).","journal-title":"Front. Neurosci."},{"issue":"1","key":"10415_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M. & Ng, P. C. SIFT missense predictions for genomes. Nat. Protoc. 11(1), 1\u20139 (2016).","journal-title":"Nat. Protoc."},{"issue":"4","key":"10415_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7(4), 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"issue":"D1","key":"10415_CR13","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47(D1), D886\u2013D894 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10415_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/bioinformatics\/btu703","volume":"31","author":"D Quang","year":"2015","unstructured":"Quang, D., Chen, Y. & Xie, X. DANN: A deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics 31(5), 761\u2013763 (2015).","journal-title":"Bioinformatics"},{"issue":"43","key":"10415_CR15","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10415_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1752-0509-6-56","volume":"6","author":"Z Gu","year":"2012","unstructured":"Gu, Z., Liu, J., Cao, K., Zhang, J. & Wang, J. Centrality-based pathway enrichment: A systematic approach for finding significant pathways dominated by key genes. BMC Syst. Biol. 6, 56 (2012).","journal-title":"BMC Syst. Biol."},{"issue":"2","key":"10415_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1214\/11-AOAS528","volume":"6","author":"L Jacob","year":"2012","unstructured":"Jacob, L., Neuvial, P. & Dudoit, S. More power via graph-structured tests for differential expression of gene networks. Ann. Appl. Stat. 6(2), 561\u2013600 (2012).","journal-title":"Ann. Appl. Stat."},{"issue":"3","key":"10415_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/bioinformatics\/bty650","volume":"35","author":"KT Do","year":"2019","unstructured":"Do, K. T., Rasp, D. J. N., Kastenm\u00fcller, G., Suhre, K. & Krumsiek, J. MoDentify: Phenotype-driven module identification in metabolomics networks at different resolutions. Bioinformatics 35(3), 532\u2013534 (2019).","journal-title":"Bioinformatics"},{"issue":"7","key":"10415_CR19","doi-asserted-by":"publisher","first-page":"e2114155","DOI":"10.1001\/jamanetworkopen.2021.14155","volume":"4","author":"N Liu","year":"2021","unstructured":"Liu, N. et al. Comparison of untargeted metabolomic profiling vs traditional metabolic screening to identify inborn errors of metabolism. JAMA Netw. Open 4(7), e2114155 (2021).","journal-title":"JAMA Netw. Open"},{"key":"10415_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms21030979","volume":"21","author":"HA Haijes","year":"2020","unstructured":"Haijes, H. A. et al. Untargeted metabolomics for metabolic diagnostic screening with automated data interpretation using a knowledge-based algorithm. Int. J. Mol. Sci. 21, 3 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"10415_CR21","first-page":"1","volume":"17","author":"LR Thistlethwaite","year":"2021","unstructured":"Thistlethwaite, L. R. et al. CTD: An information-theoretic algorithm to interpret sets of metabolomic and transcriptomic perturbations in the context of graphical models. PLoS Comput. Biol. 17, 1 (2021).","journal-title":"PLoS Comput. Biol."},{"issue":"9","key":"10415_CR22","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41436-020-0827-0","volume":"22","author":"JT Alaimo","year":"2020","unstructured":"Alaimo, J. T. et al. Integrated analysis of metabolomic profiling and exome data supplements sequence variant interpretation, classification, and diagnosis. Genet. Med. 22(9), 1560\u20131566 (2020).","journal-title":"Genet. Med."},{"key":"10415_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2017.06.014","volume":"75","author":"KL Pappan","year":"2017","unstructured":"Pappan, K. L. et al. Clinical metabolomics to segregate aromatic amino acid decarboxylase deficiency from drug-induced metabolite elevations. Pediatr. Neurol. 75, 66\u201372 (2017).","journal-title":"Pediatr. Neurol."},{"issue":"2","key":"10415_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/jalm\/jfz026","volume":"5","author":"L Ford","year":"2020","unstructured":"Ford, L. et al. Precision of a clinical metabolomics profiling platform for use in the identification of inborn errors of metabolism. J. Appl. Lab. Med. 5(2), 342\u2013356 (2020).","journal-title":"J. Appl. Lab. Med."},{"issue":"1","key":"10415_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ajmg.a.37961","volume":"173","author":"AL Duker","year":"2017","unstructured":"Duker, A. L. et al. Growth charts for individuals with rhizomelic chondrodysplasia punctata. Am. J. Med. Genet. A. 173(1), 108\u2013113 (2017).","journal-title":"Am. J. Med. Genet. A."},{"issue":"12","key":"10415_CR26","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1109\/TIT.2004.838101","volume":"50","author":"M Li","year":"2004","unstructured":"Li, M., Chen, X., Li, X., Ma, B. & Vitanyi, P. M. B. The similarity metric. IEEE Trans. Inf. Theory 50(12), 3250\u20133264 (2004).","journal-title":"IEEE Trans. Inf. Theory"},{"issue":"16","key":"10415_CR27","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","volume":"369","author":"Y Yang","year":"2013","unstructured":"Yang, Y. et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 369(16), 1502\u20131511 (2013).","journal-title":"N. Engl. J. Med."},{"key":"10415_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2105-13-8","volume":"13","author":"D Challis","year":"2012","unstructured":"Challis, D. et al. An integrative variant analysis suite for whole exome next-generation sequencing data. BMC Bioinform. 13, 8 (2012).","journal-title":"BMC Bioinform."},{"issue":"7571","key":"10415_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton, A. et al. A global reference for human genetic variation. Nature 526(7571), 68\u201374 (2015).","journal-title":"Nature"},{"issue":"4","key":"10415_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","volume":"10","author":"CS Richards","year":"2008","unstructured":"Richards, C. S. et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet. Med. 10(4), 294\u2013300 (2008).","journal-title":"Genet. Med."},{"issue":"4","key":"10415_CR31","first-page":"332","volume":"28","author":"FC Ricciuti","year":"1976","unstructured":"Ricciuti, F. C., Gelehrter, T. D. & Rosenberg, L. E. X-chromosome inactivation in human liver: Confirmation of X-linkage of ornithine transcarbamylase. Am. J. Hum. Genet. 28(4), 332\u2013338 (1976).","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10415_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1034\/j.1399-0004.1998.5440415.x","volume":"54","author":"T Yorifuji","year":"1998","unstructured":"Yorifuji, T. et al. X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency. Clin. Genet. 54(4), 349\u2013353 (1998).","journal-title":"Clin. Genet."},{"issue":"3","key":"10415_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","volume":"117","author":"NE Braverman","year":"2016","unstructured":"Braverman, N. E. et al. Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol. Genet. Metab. 117(3), 313\u2013321 (2016).","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10415_CR34","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jmg.2009.074302","volume":"47","author":"MS Ebberink","year":"2010","unstructured":"Ebberink, M. S. et al. Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene. J. Med. Genet. 47(9), 608\u2013615 (2010).","journal-title":"J. Med. Genet."},{"key":"10415_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ymgmr.2015.09.001","volume":"5","author":"C Bacino","year":"2015","unstructured":"Bacino, C. et al. A homozygous mutation in PEX16 identified by whole-exome sequencing ending a diagnostic odyssey. Mol. Genet. Metab. Rep. 5, 15\u201318 (2015).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10415_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms17071167","volume":"17","author":"A Tebani","year":"2016","unstructured":"Tebani, A., Abily-Donval, L., Afonso, C., Marret, S. & Bekri, S. Clinical metabolomics: The new metabolic window for inborn errors of metabolism investigations in the post-genomic era. Int. J. Mol. Sci. 17, 7 (2016).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10415_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2015.11.012","volume":"23","author":"CA Argmann","year":"2016","unstructured":"Argmann, C. A., Houten, S. M., Zhu, J. & Schadt, E. E. A next generation multiscale view of inborn errors of metabolism. Cell Metab. 23(1), 13\u201326 (2016).","journal-title":"Cell Metab."},{"issue":"3","key":"10415_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10545-018-0139-6","volume":"41","author":"E Graham","year":"2018","unstructured":"Graham, E. et al. Integration of genomics and metabolomics for prioritization of rare disease variants: A 2018 literature review. J. Inherit. Metab. Dis. 41(3), 435\u2013445 (2018).","journal-title":"J. Inherit. Metab. Dis."},{"key":"10415_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1752-0509-5-21","volume":"5","author":"J Krumsiek","year":"2011","unstructured":"Krumsiek, J., Suhre, K., Illig, T., Adamski, J. & Theis, F. J. Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst. Biol. 5, 21 (2011).","journal-title":"BMC Syst. Biol."},{"issue":"2","key":"10415_CR40","doi-asserted-by":"publisher","first-page":"e1000662","DOI":"10.1371\/journal.pcbi.1000662","volume":"6","author":"S Suthram","year":"2010","unstructured":"Suthram, S. et al. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput. Biol. 6(2), e1000662 (2010).","journal-title":"PLoS Comput. Biol."},{"issue":"10","key":"10415_CR41","doi-asserted-by":"publisher","first-page":"e76339","DOI":"10.1371\/journal.pone.0076339","volume":"8","author":"M Cao","year":"2013","unstructured":"Cao, M. et al. Going the distance for protein function prediction: A new distance metric for protein interaction networks. PLoS\u00a0One 8(10), e76339 (2013).","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"10415_CR42","doi-asserted-by":"publisher","first-page":"e0115692","DOI":"10.1371\/journal.pone.0115692","volume":"10","author":"Y Deng","year":"2015","unstructured":"Deng, Y., Gao, L., Wang, B. & Guo, X. HPOSim: An R package for phenotypic similarity measure and enrichment analysis based on the human phenotype ontology. PLoS\u00a0One 10(2), e0115692 (2015).","journal-title":"PLoS\u00a0One"},{"issue":"12","key":"10415_CR43","doi-asserted-by":"publisher","first-page":"e1002820","DOI":"10.1371\/journal.pcbi.1002820","volume":"8","author":"DY Cho","year":"2012","unstructured":"Cho, D. Y., Kim, Y. A. & Przytycka, T. M. Chaptexr 5: Network biology approach to complex diseases. PLoS Comput. Biol. 8(12), e1002820 (2012).","journal-title":"PLoS Comput. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10415-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:11:44Z","timestamp":1669342304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10415-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10415"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10415-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Several authors were, at the time of this study, employees of Baylor College of Medicine, which has a partnership with Baylor Genetics that derives revenue from the clinical testing referenced in this manuscript. L.R.T, X.L, L.C.B., K.R., M.F.W., N.B. and J.G.H. declare no other potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6556"}}